Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.

Annereau M, Hinterlang M, Bienayme H, Vassal G, Pinon A, Schmitt M, Denis L, Lemarchand C, Martin L, Lemare F, Abbou S, Bastid J, Tortolano L

Open source

DOI
10.3390/ph15050555
Published
2022 Apr 29
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph15050555,
  title = {Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.},
  author = {Annereau M and Hinterlang M and Bienayme H and Vassal G and Pinon A and Schmitt M and Denis L and Lemarchand C and Martin L and Lemare F and Abbou S and Bastid J and Tortolano L},
  year = {2022},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph15050555},
  url = {https://doi.org/10.3390/ph15050555}
}

RIS

TY  - JOUR
TI  - Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.
AU  - Annereau M
AU  - Hinterlang M
AU  - Bienayme H
AU  - Vassal G
AU  - Pinon A
AU  - Schmitt M
AU  - Denis L
AU  - Lemarchand C
AU  - Martin L
AU  - Lemare F
AU  - Abbou S
AU  - Bastid J
AU  - Tortolano L
PY  - 2022
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph15050555
UR  - https://doi.org/10.3390/ph15050555
ER  - 

APA

M, A., M, H., H, B., G, V., A, P., M, S., L, D., C, L., L, M., F, L., S, A., J, B., & L, T. (2022). Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph15050555

Source records